Market Access Consulting
Our Market Access Consulting
Alkemi solicits insights and creates customized evidence and reimbursement strategies for US, EU-5, and other key markets to enable patient access.
Trusted Market Access Partners
Life sciences companies partner with Alkemi to establish patient access in a rapidly evolving, evidence-based, and value-conscious health policy environment. Read more about how Alkemi delivers a value strategy to enable market access.
Our Market Access Specialization
Strategic Evidence Generation
Why is it important to be strategic when it comes to evidence generation? Designing and executing studies is resource intensive. Additionally, patient lives and well-being are at stake, so time is at a premium.
Alkemi partners with clients to create a strategy that is efficient, targeted and informed with decision-maker insights. Our evidence generation strategies often encompass rare disease, real world evidence, health economics and outcomes research to achieve market access. Our goal – like yours – is to ensure novel treatments reach the patients in greatest need.
Our team of experienced researchers and market access consultants specialize in the following: